Document Detail


Role of vasopressin in essential hypertension: racial differences.
MedLine Citation:
PMID:  9170008     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Arginine vasopressin (AVP), in addition to being an antidiuretic hormone, might also have pressor effects relevant to the maintenance of hypertension. Results from several experimental and clinical studies suggested that the pressor function of AVP is more important in low-renin hypertension and in the salt-loaded state and that it might be further maximized under sympathetic suppression. OBJECTIVE: To assess whether selective vasopressin receptor inhibition lowers the blood pressure in a racially diverse group of low-renin hypertensive subjects. METHODS: Thirty-nine hypertensive subjects (16 Caucasian, 23 African-American) eating a 200 mmol/day sodium diet were administered a single intravenous dose of a selective vasopressin receptor antagonist and their blood pressure was monitored constantly for the ensuing 3 h. The protocol was repeated 3 days later after treatment with a single oral dose of 0.4 mg clonidine. RESULTS: Of these patients, 54% had their blood sampled for determination of hormone profiles. African-Americans with hypertension had higher baseline plasma AVP levels than did Caucasians (1.13 +/- 0.05 versus 0.37 +/- 0.06 pg/ml, respectively, P < 0.05), and lower plasma renin activity (0.34 +/- 0.07 versus 1.03 +/- 0.08 ng/ml per h, respectively, P < 0.05). Selective vasopressin receptor inhibition lowered the mean arterial pressure in African-Americans but not that in Caucasians (lowering by 28 +/- 4 mmHg in African-Americans versus lowering by 5 +/- 3 mmHg in Caucasians, P < 0.05). Moreover, vasopressin receptor blockade further reduced the arterial pressure in African-Americans but not that in Caucasians after pretreatment with clonidine. CONCLUSION: AVP seems to play a more important role as a pressor hormone in maintaining the elevation of arterial pressure in African-American hypertensives than it does in Caucasian hypertensives.
Authors:
G Bakris; M Bursztyn; I Gavras; M Bresnahan; H Gavras
Related Documents :
10962518 - Relationship between plasma renin profile and leptinaemia in patients with essential hy...
57338 - Renin/angiotensin system in hypertension after traumatic renal-artery thrombosis.
11087298 - Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angio...
6352478 - Arterial wall uptake of renal renin and blood pressure control.
2373828 - Preservation of ventricular function by treatment of ventricular fibrillation with phen...
8174588 - Acute effects of balloon valvuloplasty and pacing on left ventricular performance in ch...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of hypertension     Volume:  15     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  1997 May 
Date Detail:
Created Date:  1997-08-11     Completed Date:  1997-08-11     Revised Date:  2008-08-16    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  545-50     Citation Subset:  IM    
Affiliation:
Department of Medicine, Ochsner Medical Institutions, New Orleans, Louisiana, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
African Continental Ancestry Group*
Arginine Vasopressin / analogs & derivatives,  blood,  pharmacology,  physiology*
Blood Pressure / drug effects,  physiology
European Continental Ancestry Group*
Female
Hormone Antagonists / pharmacology
Humans
Hypertension / etiology*,  physiopathology
Kidney / physiopathology
Male
Middle Aged
Receptors, Vasopressin / antagonists & inhibitors
Renin / blood
Grant Support
ID/Acronym/Agency:
HL48318/HL/NHLBI NIH HHS; RR 533/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Hormone Antagonists; 0/Receptors, Vasopressin; 113-79-1/Arginine Vasopressin; 73168-24-8/vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by ...
Next Document:  Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiote...